Trevena Announces the Closing of $4 Million Concurrent Private Placement and Warrant ExerciseGlobeNewsWire • 12/28/23
Trevena Inc. Announces $4 Million Concurrent Private Placement and Warrant ExerciseGlobeNewsWire • 12/27/23
Trevena Announces TRV045 Presentation at the American College of Neuropsychopharmacology 62nd Annual MeetingGlobeNewsWire • 12/04/23
Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn InjuriesGlobeNewsWire • 11/30/23
Trevena Reports Favorable TRV045 Topline Safety and Tolerability Data from Proof-of-Concept StudiesGlobeNewsWire • 10/16/23
Trevena Announces Completion of Initial Analysis of OLINVYK Continuous Respiratory Monitoring Data from VOLITION Study and Presentation at American Society of Anesthesiologists ConferenceGlobeNewsWire • 10/02/23
Trevena Announces Receipt of $15 Million Non-Dilutive Tranche and Provides General Business UpdateGlobeNewsWire • 09/06/23
Trevena Announces Preliminary TRV045 Data from Two Proof-of-Concept Studies Evaluating S1PR Mechanism of Action and CNS Target EngagementGlobeNewsWire • 09/06/23
Trevena Announces New Topline OLINVYK Data Highlighting Reduced Cost per Admission from ARTEMIS Real-World Outcomes StudyGlobeNewsWire • 06/26/23
Trevena Announces Receipt of Milestone Payment From Partner in China Jiangsu Nhwa PharmaceuticalGlobeNewsWire • 05/31/23
Trevena Regains Compliance with Nasdaq Listing and Reaffirms Expected Near-Term MilestonesGlobeNewsWire • 05/30/23
‘It's ridiculous.' Buy short-term Treasury bills because debt-ceiling deal will come, says bond legend Bill GrossMarket Watch • 05/09/23